| Date Filed | Type | Description |
| 08/14/2023 |
4
| Sachdev Amit (EVP, Chief Patient Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 10,031 shares
@ $350, valued at
$3.5M
|
|
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/03/2023 |
4
| Sachdev Amit (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 28,000 options to buy
@ $1.705, valued at
$47.7k
|
|
| 02/28/2023 |
4
| Sachdev Amit (EVP, Chief Patient Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 2,468 shares
@ $289.12, valued at
$713.5k
|
|
| 02/22/2023 |
4
| Sachdev Amit (EVP, Chief Patient Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 3,498 shares
@ $292.85, valued at
$1M
|
|
| 02/14/2023 |
4
| Sachdev Amit (EVP, Chief Patient Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 2,611 shares
@ $294.33, valued at
$768.5k
Paid exercise price by delivering 4,657 shares
@ $298.26, valued at
$1.4M
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2022 |
4
| Sachdev Amit (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 12,000 options to buy
@ $5.1, valued at
$61.2k
|
|
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Sachdev Amit (EVP, Chief Patient Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 2,491 shares
@ $237.74, valued at
$592.2k
|
|
| 11/16/2021 |
4
| Sachdev Amit (EVP, Chief Patient Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 21 shares
@ $186.78, valued at
$3.9k
Sold 30 shares
@ $187.48, valued at
$5.6k
|
|
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Sachdev Amit (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 10,000 options to buy
@ $9.99, valued at
$99.9k
|
|
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2020 |
4
| Sachdev Amit (EVP, Chief Patient Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 12 shares
@ $222.5, valued at
$2.7k
Sold 22 shares
@ $223.76, valued at
$4.9k
Sold 8 shares
@ $224.44, valued at
$1.8k
|
|
| 08/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2020 |
4
| Sachdev Amit (EVP, Chief Patient Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 1 shares
@ $274.67, valued at
$274.7
Sold 3 shares
@ $276.21, valued at
$828.6
Sold 1 shares
@ $278.42, valued at
$278.4
Sold 10 shares
@ $280.34, valued at
$2.8k
Sold 2 shares
@ $281.65, valued at
$563.3
Sold 5 shares
@ $283.01, valued at
$1.4k
Sold 6 shares
@ $284.95, valued at
$1.7k
Sold 11 shares
@ $286.63, valued at
$3.2k
Sold 13 shares
@ $287.65, valued at
$3.7k
Sold 6 shares
@ $288.36, valued at
$1.7k
|
|
| 05/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2020 |
4
| Sachdev Amit (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 10,000 options to buy
@ $5.6, valued at
$56k
|
|
| 02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2020 |
4
| Sachdev Amit (EVP, Chief Patient Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Granted 15,170 shares
@ $0
Granted 9,800 shares
@ $0
Granted 10,323 shares
@ $0 |
|
| 02/05/2020 |
4
| Sachdev Amit (EVP, Chief Patient Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 500 shares
@ $228.89, valued at
$114.4k
Sold 714 shares
@ $230.07, valued at
$164.3k
Sold 1,306 shares
@ $231.25, valued at
$302k
Sold 1,177 shares
@ $231.92, valued at
$273k
Sold 400 shares
@ $232.87, valued at
$93.1k
Exercised 2,156 options to buy
@ $91.05, valued at
$196.3k
Exercised 1,941 options to buy
@ $86.52, valued at
$167.9k
|
|
| 01/21/2020 |
4
| Sachdev Amit (EVP, Chief Patient Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 5,000 shares
@ $235, valued at
$1.2M
Exercised 5,000 options to buy
@ $109.14, valued at
$545.7k
|
|
| 01/10/2020 |
4
| Sachdev Amit (EVP, Chief Patient Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 5,000 shares
@ $230, valued at
$1.2M
Exercised 5,000 options to buy
@ $109.14, valued at
$545.7k
|
|
|